Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03849937 · ClinicalTrials.gov registry record · NA

Changing Talk Online (CHATO) Study

A NA study, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
219
Enrollment target

NCT03849937: Completed NA study, sponsored by University of Kansas Medical Center.

NCT03849937 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 219 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03849937, a NA study, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
219 participants
Enrollment target

Study Summary

Objectives AIM 1. Establish acceptability and preliminary efficacy of online CHATO modules through pilot testing with NH staff. AIM 2. Develop and pilot test the data collection tool with consultant and advisory panel input. Interviews of NH administrators and staff who participate in the pilot testing of CHATO and a process evaluation will be used to identify and develop supports for implementation and sustainability in preparation for future CHATO testing. Design and Outcomes The R61 will prepare for the R01 pragmatic trial by establishing feasibility of online modules and preliminary efficacy of CHATO with NH staff. The research design is a randomized clinical trial. One NH will provide initial feasibility testing. Any modifications to the modules will be made. Then six nursing homes (estimated N=150 staff) will be randomly assigned to intervention or wait-list control groups. The primary outcome will be knowledge gain for staff completing CHATO training. Additional outcomes include resident quality measures related to behavioral and psychological symptoms of dementia (BPSD) on both resident and facility levels and facility level data related to inappropriate use of psychotropic medications to control BPSD. Implementation strategies will be assessed by survey and leadership interviews completed by an external evaluator. Interventions and Duration Changing Talk Online (CHATO) training is a course is to increase awareness of the importance of effective communication with older adults and to use evidence-based person-centered communication during interactions with older adults in nursing homes and other health care settings. The total program is approximately 3 hours, split into 3 modules. Each module is approximately an hour, depending on the individual user. Each NH will work with the research team for three months to plan, implement, and collect data. Sample Size and Population This course is designed for staff in nursing homes, independent and assisted livin

Primary Outcome

CHATO Knowledge Test was given to participants pre training and post training. Scoring: 13 items scored incorrect (0) or correct (1). Test score was calculated as the percentage of correct answers (0-100%). The mean percentage was used for each group in the the analysis. Two forms (Forms A and B) measures knowledge gained from training.

Interventions

  • BEHAVIORAL Changing Talk Online (CHATO)

Trial Details

FieldValue
Enrollment Target 219 participants
Start Date 2019-09-03
Est. Completion 2020-08-31
Phase NA
University of Kansas Medical Center

408 total trials

What the finished NCT03849937 record still lists

NCT03849937 is an interventional study that assigns participants to a tested intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 1 intervention - of which Changing Talk Online (CHATO) is the first listed.

NCT03849937 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03849937 about?

NCT03849937 is a clinical study titled "Changing Talk Online (CHATO) Study". Objectives AIM 1. Establish acceptability and preliminary efficacy of online CHATO modules through pilot testing with NH staff. AIM 2. Develop and pilot test the data collection tool with consultant and advisory panel input. Interviews of NH administrators and staff who participate in the pilot tes...

What is the current status of trial NCT03849937?

This trial is currently completed. It is a NA study. The enrollment target is 219 participants. The study started on 2019-09-03. Estimated completion is 2020-08-31.

What interventions are being tested in trial NCT03849937?

The interventions under investigation include: Changing Talk Online (CHATO) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03849937?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03849937's enrollment target sits among peer trials

219 485th of 2000 higher than 1,516 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05196035 · 219 participants · Phase 3

    A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria

  • NCT05608434 · 219 participants · Phase 1

    Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

  • NCT05773144 · 219 participants · NA

    Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

  • NCT05907980 · 219 participants · Phase 1

    A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03849937, the US trial registry maintained by the National Library of Medicine. NCT03849937 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.